期刊文献+

miR-183靶向CX3CL1基因调控肝癌细胞MICA/B表达和增加NK细胞对肝癌细胞杀伤作用 被引量:4

Molecular mechanism of miR-183 targeting CX3CL1 gene to regulate MICA/B expression in hepatocellular carcinoma cells and increase NK cell killing effect
下载PDF
导出
摘要 目的探讨miR-183对肝癌细胞MHC-Ⅰ类相关蛋白A/B(MICA/B)表达和自然杀伤(NK)细胞杀伤作用影响及其分子机制。方法实验设置miR-con组、miR-183组、anti-miR-con组、anti-miR-183组、pcDNA组、pcDNA-CX3CL1组、antimiR-183+si-con组、anti-miR-183+CX3CL1组、对照(NC)组。实时荧光定量PCR(RT-qPCR)检测miR-183和CX3CL1 m RNA表达水平;蛋白质印迹(Western blot)法检测CX3CL1、MICA和MICB蛋白表达;流式细胞术检测肝癌细胞表面MICA/B的表达;NK细胞与肝癌细胞共培养后,细胞计数试剂盒8(CCK-8)法检测NK细胞对肝癌细胞的杀伤作用;酶联免疫吸附法(ELISA)法检测肝癌细胞与NK细胞共培养后培养液中肿瘤坏死因子-α(TNF-α)和干扰素γ(IFN-γ)水平;荧光素酶报告实验检测miR-183和CX3CL1的靶向关系。结果肝癌组织和肝癌细胞中miR-183高表达,CX3CL1、MICA和MICB低表达。干扰miR-183表达和过表达CX3CL1,肝癌细胞中MICA、MICB阳性表达率显著升高,与NK细胞共培养后TNF-α和IFN-γ水平显著升高,NK细胞对肝癌细胞的杀伤率显著升高(P<0.05)。miR-183靶向调控CX3CL1,沉默CX3CL1逆转了干扰miR-183对肝癌细胞MICA/B表达和NK细胞杀伤作用的影响。结论抑制表达miR-183可增加肝癌细胞MICA/B表达,增加NK细胞对肝癌细胞的杀伤作用,其机制可能与CX3CL1有关。 The purpose of this experiment was to investigate the effect miR-183 on the expression of MHC-Ⅰ related protein A/B(MICA/B) and the killing effect of natural killer(NK) cells against liver cancer cells. Hun3 B liver cancer cells were divided into miR-con group, miR-183 group, anti-miR-con group, anti-miR-183 group,pcDNA group, pcDNA-CX3 CL1 group, anti-miR-183+si-con group, anti-miR-183+CX3 CL1 group and normal control group. Real-time fluorescence quantitative PCR(RT-qPCR) was used to detect the mRNA expressions of miR-183 and CX3 CL1 in liver cancer cells;Western blot was used to detect the expression of CX3 CL1 protein, and flow cytometry was used to detect the expression of MICA/B on the surface of liver cancer cells. NK cells were isolated from peripheral blood, and co-culture with liver cancer cells of the above groups. Then cell counting kit 8(CCK-8) method was used to detect the killing effect of NK cells on liver cancer cells;enzyme-linked immunosorbent assay(ELISA) was used to detect the levels of tumor necrosis factor-α(TNF-α) and interferon-γ(IFN-γ) in the culture medium of liver cancer cells and NK cells after co-culture. miR-183 was co-transfected with CX3 CL1 wild-type and mutant luciferase vectors, and the targeting relationship between miR-183 and CX3 CL1 was detected by luciferase report experiment. Data showed that miR-183 was highly expressed in liver cancer cells, while CX3 CL1, MICA and MICB were lowly expressed. miR-183 expression interference or CX3 CL1 overexpression could significantly promote the positive expression rates of MICA and MICB in liver cancer cells, un-regulate the levels of TNF-α and IFN-γ after co-culture with NK cells, and increase the killing rate of NK cells on liver cancer cells. miR-183 targeted and regulated CX3 CL1. And after interfering with the expression of miR-183 and CX3 CL1, the positive expression rates of MICA and MICB in liver cancer cells were significantly reduced, the levels of TNF-α and IFN-γ were significantly reduced, and the killing rate of NK cells on liver cancer cells was significantly reduced. The above data indicate that inhibiting the expression of miR-183 may increase the expression of MICA/B in liver cancer cells by increasing the expression of CX3 CL1, thus increase the killing effect of NK cells on liver cancer cells.
作者 靳海科 刘意 武卫 JIN Haike;LIU Yi;WU Wei(Department of Microbiology and Immunology,Henan Vocational College of Nursing,Anyang 455000,China;School of Medical Technology and Engineering,Zhengzhou Railway Vocational and Technical College,Zhengzhou 450052,China;Clinical Laboratory,Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处 《免疫学杂志》 CAS CSCD 北大核心 2021年第3期192-201,共10页 Immunological Journal
关键词 miR-183 CX3CL1 肝癌 MICA/B 自然杀伤细胞 杀伤作用 miR-183 CX3CL1 Liver cancer MICA/B Natural killer cells Killing effect
  • 相关文献

参考文献12

二级参考文献131

  • 1Sun JC,Lanier LL.Natural killer cells remember:An evolutionary bridge between innate and adaptive immunity[J].Eur J Immunol,2009,39(8):2059-2064.
  • 2Farag SS,Fehniger TA,Ruggeri L,et al.Natural killer cell receptors:new biology and insights into the graft-versus-leukemia effect[J].Blood,2002,100(6):1935-1947.
  • 3Cho D,Campana D.Expansion and activation of natural killer cells for cancer immumotherapy[J].Korean J Lab Med,2009,29(2):89-96.
  • 4Castriconi R,Dondero A,Cilli M.Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice[J].Cancer Immunol Immun,2007,56(11):1733-1742.
  • 5Robertson MJ,Ritz J.Biology and clinical relevance of human natural killer cells[J].Blood,1990,76(12):2421-2438.
  • 6Vivier E,Nunes JA,Vely F.Natural killer cell signaling pathways[J].Science,2004,306(5701):1517-1519.
  • 7Ljunggren HG,Malmberg KJ.Prospects for the use of NK cells in immunotherapy of human cancer[J].Nat Rev Immunol,2007,7(5):329-339.
  • 8Ruggeri L,Capanni M.Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J].Science,2002,295(5562):2097-2100.
  • 9Pietra G,Manzini C,Vitale M,et al.Natural killer cells kill human melanoma cells with characteristics of cancer stem cells[J].Int Immunol,2009,21(7):793-801.
  • 10Pegram HJ,Haynes NM,Smyth MJ,et al.Characterizing the anti-tumor function of adoptively transferred NK cells in vivo[J].Cancer Immunol Immun,2010,59(8):1235-1246.

共引文献66

同被引文献26

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部